19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11241446
APP PUB NO 20200155576A1
SERIAL NO

16428386

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are 19-nor C3,3-disubstituted C21-pyrazolyl steroids of Formula (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SAGE THERAPEUTICS INC215 FIRST STREET CAMBRIDGE MA 02142

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beresis, Richard Thomas Shanghai, CN 30 573
Harrison, Boyd L Princeton Junction, US 126 1642
Martinez, Botella Gabriel Wayland, US 132 1511
Robichaud, Albert Jean Boston, US 146 1755
Salituro, Francesco G Marlborough, US 216 2924

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Aug 8, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 8, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 8, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00